| Dr Lauren Winslow Fisher, MD | |
|
9135 Sw Barnes Rd Ste 461, Portland, OR 97225-6643 | |
| (503) 215-8699 | |
| Not Available |
| Full Name | Dr Lauren Winslow Fisher |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 14 Years |
| Location | 9135 Sw Barnes Rd Ste 461, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215253778 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD60458730 (Washington) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | MD208912 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
"The Global Health Initiative [GHI] will focus more heavily on countries' own goals for development, explained Amie Batson, deputy assistant administrator for Global Health at USAID at a panel at the Global Health Council Conference on Thursday," GlobalPost's "Global Pulse" blog reports.
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.
"We understand tonight that the Food and Drug Administration has reported a confirmed positive sample of E coli 0157:H7 in an open bag of spinach from a consumer who became ill in this outbreak.
San Francisco's women firefighters are exposed to higher levels of certain toxic PFAS chemicals than women working in downtown San Francisco offices, shows a new study led by researchers at the University of California, Berkeley, the University of California, San Francisco, and Silent Spring Institute.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
› Verified 6 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
"The Global Health Initiative [GHI] will focus more heavily on countries' own goals for development, explained Amie Batson, deputy assistant administrator for Global Health at USAID at a panel at the Global Health Council Conference on Thursday," GlobalPost's "Global Pulse" blog reports.
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.
"We understand tonight that the Food and Drug Administration has reported a confirmed positive sample of E coli 0157:H7 in an open bag of spinach from a consumer who became ill in this outbreak.
San Francisco's women firefighters are exposed to higher levels of certain toxic PFAS chemicals than women working in downtown San Francisco offices, shows a new study led by researchers at the University of California, Berkeley, the University of California, San Francisco, and Silent Spring Institute.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
› Verified 6 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
"The Global Health Initiative [GHI] will focus more heavily on countries' own goals for development, explained Amie Batson, deputy assistant administrator for Global Health at USAID at a panel at the Global Health Council Conference on Thursday," GlobalPost's "Global Pulse" blog reports.
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.
"We understand tonight that the Food and Drug Administration has reported a confirmed positive sample of E coli 0157:H7 in an open bag of spinach from a consumer who became ill in this outbreak.
San Francisco's women firefighters are exposed to higher levels of certain toxic PFAS chemicals than women working in downtown San Francisco offices, shows a new study led by researchers at the University of California, Berkeley, the University of California, San Francisco, and Silent Spring Institute.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
› Verified 6 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114015971 PECOS PAC ID: 9335057447 Enrollment ID: O20031117000153 |
News Archive
"The Global Health Initiative [GHI] will focus more heavily on countries' own goals for development, explained Amie Batson, deputy assistant administrator for Global Health at USAID at a panel at the Global Health Council Conference on Thursday," GlobalPost's "Global Pulse" blog reports.
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.
"We understand tonight that the Food and Drug Administration has reported a confirmed positive sample of E coli 0157:H7 in an open bag of spinach from a consumer who became ill in this outbreak.
San Francisco's women firefighters are exposed to higher levels of certain toxic PFAS chemicals than women working in downtown San Francisco offices, shows a new study led by researchers at the University of California, Berkeley, the University of California, San Francisco, and Silent Spring Institute.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lauren Winslow Fisher, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Dr Lauren Winslow Fisher, MD 9135 Sw Barnes Rd Ste 461, Portland, OR 97225-6643 Ph: (503) 215-8699 |
News Archive
"The Global Health Initiative [GHI] will focus more heavily on countries' own goals for development, explained Amie Batson, deputy assistant administrator for Global Health at USAID at a panel at the Global Health Council Conference on Thursday," GlobalPost's "Global Pulse" blog reports.
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.
"We understand tonight that the Food and Drug Administration has reported a confirmed positive sample of E coli 0157:H7 in an open bag of spinach from a consumer who became ill in this outbreak.
San Francisco's women firefighters are exposed to higher levels of certain toxic PFAS chemicals than women working in downtown San Francisco offices, shows a new study led by researchers at the University of California, Berkeley, the University of California, San Francisco, and Silent Spring Institute.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
› Verified 6 days ago
Danielle Laure Erb, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1815 Sw Marlow Ave, Suite 110, Portland, OR 97225 Phone: 503-296-0918 Fax: 503-296-6158 | |
Dr. Duncan Soule, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2617 Nw Thurman St, Portland, OR 97210 Phone: 503-224-9010 Fax: 503-224-5551 | |
Dr. Stephanie K Liu, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 10940 Sw Barnes Rd # 375, Portland, OR 97225 Phone: 646-591-7011 | |
Thomas Lorish, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9155 Sw Barnes Rd, #440, Portland, OR 97225 Phone: 503-216-7145 Fax: 503-216-4071 | |
Dr. Lynette Santos Malik, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3600 N Interstate Ave, Department Of Physical Medicine, Portland, OR 97227 Phone: 503-331-3070 Fax: 503-331-3089 | |
Dr. Gary Allen Ward, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1040 Nw 22nd Ave, Suite 320, Portland, OR 97210 Phone: 503-413-6294 Fax: 503-413-7780 | |
Steven James Janselewitz, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2801 N Gantenbein Ave, Portland, OR 97227 Phone: 503-413-4505 |